Really bold statement by Brean since they just raised 110 million with the recent offering. Mr. Obvious.
If you follow the logic from KERX recently, that will be the next secondary price offering. Just wait and see.
Bios suck past Phase III. People need to remember that. There is too much cost associated with launching a drug which is why they usually drop consistently after approval. Look at VVUS, ARNA, KERX!!! People have to be happy with 25% now, the 50% to 75% gains are a thing of the past now. Shorts won't let that happen with inside help from their friends the evil, MM.
Look for drop back to sub $10 range in a few weeks. Approvals are the kiss of death for stocks believe it or not. Now it's time to raise money to market and manufacture which will take time and resources. Time to move on as this pig is done now.
I see you are starting to see the light now, good for you. Hope it works for you. As far as what stock to play while you are waiting, you can play any one. That's the beauty of playing ranges. Research the charts of the stocks and look for the beginning of a upward trend. As long as you are getting in and out, you really don't have to learns what the stock does, just how it trades. Let the professionals worry about that part. If a stock makes two higher highs and two higher lows, than watch it. This is the beginning of a channel trade. Watch how it performs over a few weeks to get the confidence to play the next one. It takes some practice and confidence. If you have a good bit of money to play with then you can get into more safer stocks but they cost more.
What's the connection here? Why are people following FDA decision on RMTI non KERX message board?
Yes you do and no takers for either! Their PPS has dropped over 80% since approval and still no takers? Want to know why?? Go figure it out yourself.
You need to read the statement, they are not Upgrading VVUS, they are initiating coverage. There is a big difference fool!
I'm glad you were not raised as a pompus individual. Everyone raise their hands if you care that beta is close to 100K shares????Nope don't see any. I guess no one cares. I should buy your 88K to get you off this board!
Too convenient to be that accurate. Collusion is the word of the day. They don't have a crystal ball, they just talk to people behind the scenes. The SEC would never be smart enough to put that together so we just take it with a grain of salt like everything else. JP Morgan gets a good buy in price and sells the shares at a premium right off the bat. Must be nice to have money and influence.
The levels are already way to high for where we are trading. No one will raise anything or initiate now until sales numbers come in. Europe in the summer will be the next possible move up in estimates.
Until we gat above the $13.80 level we are not trading technically as we are below all the major moving averages. We nee to trade between them soon and return some normalcy or we will continue to have these wild swings.
This will be very volatile until lunch time today. Stock prices may flip flop all day between red and green as people decide how to play the latest news. You could get several $0.50 moves today so if you dare?
If the earnings are more negating now than last year than yes they are worth less. What sales do they have to offset all the costs for the approval and launch. It's a numbers game
That's typical with these biotechs especially after approval. Forget the buyout nonsense right after approval, forget the analysts numbers, it's all about the sales and they need cash to do it. Just like clockwork. Take notes from this and compare it to the next stock getting approval and you will see the pattern.
Ah, you finally realize that common sense does not prevail in this arena. The price is whatever the MM make it out to be to make them the most money. They are all behind this and the deal probably got done at the last conference. Where was the last conference held? JP Morgan and who is the lead underwriter for this secondary? JP Morgan. See how it works.